Nemolizumab (Nemluvio, Galderma) Improves Itch and Skin Lesions in AD Patients for Up to Two Years June 10, 2025
RAD News: Dupilumab (Dupixent, Sanofi & Regeneron) Performs Well in AD Patients With Darker Skin Tones June 9, 2025
